Homology modeling in drug discovery: Overview, current applications, and future perspectives
MT Muhammed, E Aki‐Yalcin - Chemical biology & drug design, 2019 - Wiley Online Library
Homology modeling is one of the computational structure prediction methods that are used
to determine protein 3D structure from its amino acid sequence. It is considered to be the …
to determine protein 3D structure from its amino acid sequence. It is considered to be the …
Kinases control of regulated cell death revealing druggable targets for Parkinson's disease
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder in the
world. Motor impairment seen in PD is associated with dopaminergic neurotoxicity in the …
world. Motor impairment seen in PD is associated with dopaminergic neurotoxicity in the …
Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis
Stimulation of cells with TNFα can promote distinct cell death pathways, including RIPK1-
independent apoptosis, necroptosis, and RIPK1-dependent apoptosis (RDA)—the latter of …
independent apoptosis, necroptosis, and RIPK1-dependent apoptosis (RDA)—the latter of …
LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia
Long-term exposure to elevated levels of manganese (Mn) causes manganism, a
neurodegenerative disorder with Parkinson's disease (PD)-like symptoms. Increasing …
neurodegenerative disorder with Parkinson's disease (PD)-like symptoms. Increasing …
The development and design strategy of leucine-rich repeat kinase 2 inhibitors: promising therapeutic agents for Parkinson's disease
X Tang, S Xing, M Ma, Z Xu, Q Guan… - Journal of Medicinal …, 2023 - ACS Publications
Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting millions of
people worldwide. Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are …
people worldwide. Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are …
Allosteric inhibition of Parkinson's-linked LRRK2 by constrained peptides
LG Helton, A Soliman, F von Zweydorf… - ACS chemical …, 2021 - ACS Publications
Leucine-Rich Repeat Kinase 2 (LRRK2) is a large, multidomain protein with dual kinase and
GTPase function that is commonly mutated in both familial and idiopathic Parkinson's …
GTPase function that is commonly mutated in both familial and idiopathic Parkinson's …
Toxin neutralization using alternative binding proteins
TP Jenkins, T Fryer, RI Dehli, JA Jürgensen… - Toxins, 2019 - mdpi.com
Animal toxins present a major threat to human health worldwide, predominantly through
snakebite envenomings, which are responsible for over 100,000 deaths each year. To date …
snakebite envenomings, which are responsible for over 100,000 deaths each year. To date …
Molecular pathways involved in LRRK2-linked Parkinson's disease: a systematic review
AI Ravinther, HD Dewadas, SR Tong, CN Foo… - International Journal of …, 2022 - mdpi.com
Parkinson's disease is one of the most common neurodegenerative diseases affecting the
ageing population, with a prevalence that has doubled over the last 30 years. As the …
ageing population, with a prevalence that has doubled over the last 30 years. As the …
Doubly constrained C-terminal of roc (COR) domain-derived peptides inhibit leucine-rich repeat kinase 2 (LRRK2) dimerization
P Pathak, KK Alexander, LG Helton… - ACS chemical …, 2023 - ACS Publications
Missense mutations along the leucine-rich repeat kinase 2 (LRRK2) protein are a major
contributor to Parkinson's Disease (PD), the second most commonly occurring …
contributor to Parkinson's Disease (PD), the second most commonly occurring …
LRRK2 structure-based activation mechanism and pathogenesis
X Zhang, A Kortholt - Biomolecules, 2023 - mdpi.com
Mutations in the multidomain protein Leucine-rich-repeat kinase 2 (LRRK2) have been
identified as a genetic risk factor for both sporadic and familial Parkinson's disease (PD) …
identified as a genetic risk factor for both sporadic and familial Parkinson's disease (PD) …